Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Titan Biotech Financial Results

Titan Biotech Limited approved its audited financial results for the fiscal year ended March 31, 2026. The Board also recommended a dividend of Rs. 0.50 per share.

Source

BSE filing, NSE: TITANBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Titan Biotech Ltd: key numbers

Share price
₹352.00
Market cap
₹1,818 Cr
Revenue (annual)
₹206.2 Cr
Net profit (annual)
₹29.89 Cr
P/E (TTM)
53.7×Sector 34.1×
Promoter holding
55.78%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Titan Biotech Ltd

All →

Other financial results announcements

All →